Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...

The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, ...

Pregnancy care is now being transformed from its traditional, observational monitoring approach into a proactive, precision-led process, thanks to antenatal genomics.

Researchers at the University of Nottingham have developed a new genetic test that can diagnose brain tumours in as little as 2 hours. The test, called ROBIN, uses PromethION nanopore sequencing to ...

Medicare Part B covers various genetic tests for diagnosing genetic conditions, identifying cancer risks, and predicting medication responses if a doctor deems them medically necessary. The cost of ...

Global Market OverviewThe Global Non-Invasive Prenatal Testing (NIPT) Market is projected to expand at a CAGR of 16% by 2029, ...

Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...

The global DNA Polymerase Market is projected to expand from USD 397.7 million in 2025 to USD 725.8 million by 2035, growing at a CAGR of 6.2% during the forecast period. According to Future Market ...